BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7539875)

  • 1. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.
    Remington G
    J Psychiatry Neurosci; 2003 Jul; 28(4):275-84. PubMed ID: 12921222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets for treating cognitive dysfunction in schizophrenia.
    Gray JA; Roth BL
    Schizophr Bull; 2007 Sep; 33(5):1100-19. PubMed ID: 17617664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex scenario behind the term antipsychotic drug.
    Riva MA; Cattaneo A
    Eur Neuropsychopharmacol; 2024 Mar; 80():3-4. PubMed ID: 38128334
    [No Abstract]   [Full Text] [Related]  

  • 4. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
    Pei Y; Asif-Malik A; Canales JJ
    Front Neurosci; 2016; 10():148. PubMed ID: 27092049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine, a fast-off-D2 antipsychotic.
    Seeman P
    ACS Chem Neurosci; 2014 Jan; 5(1):24-9. PubMed ID: 24219174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.
    Adkins DE; Aberg K; McClay JL; Bukszár J; Zhao Z; Jia P; Stroup TS; Perkins D; McEvoy JP; Lieberman JA; Sullivan PF; van den Oord EJ
    Mol Psychiatry; 2011 Mar; 16(3):321-32. PubMed ID: 20195266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.
    Pickar D; Vinik J; Bartko JJ
    PLoS One; 2008 Sep; 3(9):e3150. PubMed ID: 18781198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing clozapine treatment despite neutropenia.
    Esposito D; Rouillon F; Limosin F
    Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do the atypical antipsychotics work?
    Ananth J; Burgoyne KS; Gadasalli R; Aquino S
    J Psychiatry Neurosci; 2001 Nov; 26(5):385-94. PubMed ID: 11762206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.
    Miceli JJ; Wilner KD; Hansen RA; Johnson AC; Apseloff G; Gerber N
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):5S-13S. PubMed ID: 10771448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The newer, 'atypical' antipsychotic drugs--their development and current therapeutic use.
    Kendrick T
    Br J Gen Pract; 1999 Sep; 49(446):745-9. PubMed ID: 10756621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.
    Pijl H; Meinders AE
    Drug Saf; 1996 May; 14(5):329-42. PubMed ID: 8800628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community care of patients with schizophrenia: the role of the primary health care team.
    King M; Nazareth I
    Br J Gen Pract; 1996 Apr; 46(405):231-7. PubMed ID: 8703526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for pharmacotherapy of schizophrenia.
    Pickar D
    Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy of schizophrenia: a review.
    Sigmundson HK
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
    Hall H; Halldin C; Nyberg S; Farde L; Sedvall G
    Eur Neuropsychopharmacol; 1995 Mar; 5(1):19-25. PubMed ID: 7542051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to clozapine as a predictor of risperidone response in schizophrenia.
    Mok H; Yatham LN
    Am J Psychiatry; 1994 Sep; 151(9):1393-4. PubMed ID: 7520672
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in the pharmacotherapy of schizophrenia.
    Meltzer HY; Lee MA; Ranjan R
    Acta Psychiatr Scand Suppl; 1994; 384():95-101. PubMed ID: 7533472
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.